These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7976734)

  • 1. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance.
    Christadoss P; Shenoy M; Oshima M; Atassi MZ
    Adv Exp Med Biol; 1994; 347():65-75. PubMed ID: 7976734
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
    Rosenberg JS; Oshima M; Atassi MZ
    J Immunol; 1996 Oct; 157(7):3192-9. PubMed ID: 8816433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
    Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis.
    Balasa B; Deng C; Lee J; Christadoss P; Sarvetnick N
    J Immunol; 1998 Sep; 161(6):2856-62. PubMed ID: 9743346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response.
    Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; van Eden W; de Baets MH
    Eur J Immunol; 1996 Dec; 26(12):2866-75. PubMed ID: 8977279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered peptide ligands of a myasthenogenic epitope as modulators of specific T-cell responses.
    Kirshner SL; Zisman E; Fridkin M; Sela M; Mozes E
    Scand J Immunol; 1996 Nov; 44(5):512-21. PubMed ID: 8947604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.
    Christadoss P; Lindstrom JM; Talal N; Duvic CR; Kalantri A; Shenoy M
    J Immunol; 1986 Sep; 137(6):1845-9. PubMed ID: 2943805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis.
    Protti MP; Manfredi AA; Straub C; Howard JF; Conti-Tronconi BM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7792-6. PubMed ID: 2145582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholine receptor-specific human T-lymphocyte lines.
    Hohlfeld R; Toyka KV; Michels M; Heininger K; Conti-Tronconi B; Tzartos SJ
    Ann N Y Acad Sci; 1987; 505():27-38. PubMed ID: 2446551
    [No Abstract]   [Full Text] [Related]  

  • 16. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.
    Melms A; Malcherek G; Gern U; Wiethölter H; Müller CA; Schoepfer R; Lindstrom J
    Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
    Schountz T; Kasselman JP; Ford SR; Murray JS
    Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal administration of synthetic acetylcholine receptor T epitopes affects the immune response to the acetylcholine receptor and prevents experimental myasthenia gravis.
    Karachunski PI; Ostlie NS; Okita DK; Conti-Fine BM
    Ann N Y Acad Sci; 1998 May; 841():560-4. PubMed ID: 9668295
    [No Abstract]   [Full Text] [Related]  

  • 19. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats.
    Baggi F; Annoni A; Ubiali F; Milani M; Longhi R; Scaioli W; Cornelio F; Mantegazza R; Antozzi C
    J Immunol; 2004 Feb; 172(4):2697-703. PubMed ID: 14764745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T-epitope repertoire on the human acetylcholine receptor alpha subunit in severe myasthenia gravis: a study with synthetic peptides.
    Manfredi AA; Protti MP; Wu XD; Howard JF; Conti-Tronconi BM
    Neurology; 1992 May; 42(5):1092-100. PubMed ID: 1374548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.